Breaking News Instant updates and real-time market news.

CNCE

Concert Pharmaceuticals

$15.13

-0.54 (-3.45%)

12:33
03/25/19
03/25
12:33
03/25/19
12:33

RTW Investment reports 7.7% passive stake in Concert Pharmaceuticals

In a regulatory filing, RTW Investment disclosed a 7.7% stake in Concert Pharmaceuticals, representing 1.8M shares. The filing does not allow for activism.

CNCE Concert Pharmaceuticals
$15.13

-0.54 (-3.45%)

09/13/18
JANY
09/13/18
INITIATION
JANY
Neutral
Concert Pharmaceuticals initiated with a Neutral at Janney Montgomery Scott
09/13/18
JANY
09/13/18
INITIATION
Target $17
JANY
Neutral
Janney Montgomery Scott starts Concert Pharmaceuticals at Neutral
As previously reported, Janney Montgomery Scott initiated Concert Pharmaceuticals (CNCE) with a Neutral rating, with analyst Esther Hong setting a $17 fair value estimate on the shares. She believes AVP-786, which is in Phase 3 in Alzheimer's agitation, has blockbuster potential and she is positive on its lead program, CTP-543 for the treatment of Alopecia Areata. However, Hong remains on the sidelines pending the final decision on CTP-543's patent after Incyte filed an Inter Partes Review petition, noting that the PTAB granted a rehearing request, which it rarely does. She sees the IPR ruling as difficult to predict at this stage.
12/18/18
MZHO
12/18/18
NO CHANGE
Target $26
MZHO
Buy
Concert remains best-in-class after Aclaris data, says Mizuho
Mizuho analyst Difei Yang reiterates a Buy rating on Concert Pharmaceuticals (CNCE) after competitor Aclaris Therapeutics (ACRS) reported data from its topical Janus kinase 1/3 inhibitor for the treatment of alopecia areata. While a number of patients were responders in the eyebrow and alopecia totalis/alopecia universalis Phase 2 trials, improvements on Severity of Alopecia Tool scores were not disclosed and a few patients withdrew from the studies, Yang tells investors in a research note. The analyst sees Concert Pharmaceuticals' CTP-543 as best-in-class and more competitive for the treatment of moderate/severe alopecia areata. Yang keeps a $26 price target on Concert shares.
02/07/19
MZHO
02/07/19
NO CHANGE
Target $26
MZHO
Buy
Concert Pharmaceuticals undervalued ahead of 2019 catalysts, says Mizuho
After holding investor meetings with management, Mizuho analyst Difei Yang says shares of Concert Pharmaceuticals are undervalued ahead of important catalysts in 2019. Catalysts include a Patent Trial and Appeal Board decision related to the CTP-543 patent litigation expected by April 9, top-line data from the CTP-543 12mg cohort in Q3, Phase 3 data in Alzheimer's Agitation possibly in Q2, and Phase 1 data from CTP-692 in schizophrenia in the first half of 2019, Yang tells investors in a research note. The analyst sees "strong potential" in CTP-543, regardless of the intellectual property litigation outcome, and believes the asset has potential to be first-to-market for the treatment of alopecia areata. She keeps a Buy rating on Concert Pharmaceuticals with a $26 price target.

TODAY'S FREE FLY STORIES

FMCC

Freddie Mac

$0.00

(0.00%)

21:42
12/05/19
12/05
21:42
12/05/19
21:42
Initiation
Freddie Mac initiated  »

Freddie Mac initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$47.16

1.88 (4.15%)

21:00
12/05/19
12/05
21:00
12/05/19
21:00
Syndicate
GDS Holdings 5.49M share Secondary priced at $45.50 »

JPMorgan, RBC Capital and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 06

    Dec

BIG

Big Lots

$19.17

-0.75 (-3.77%)

, GCO

Genesco

$36.94

0.38 (1.04%)

20:25
12/05/19
12/05
20:25
12/05/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BIG

Big Lots

$19.17

-0.75 (-3.77%)

GCO

Genesco

$36.94

0.38 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

UNVR

Univar

$23.15

0.22 (0.96%)

20:10
12/05/19
12/05
20:10
12/05/19
20:10
Hot Stocks
Univar to sell environmental sciences business to AEA Investors for $195M »

Univar announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$3.10

-0.195 (-5.93%)

20:04
12/05/19
12/05
20:04
12/05/19
20:04
Syndicate
Plug Power 40M share Secondary priced at $2.75 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RGLD

Royal Gold

$117.91

0.64 (0.55%)

, TECK

Teck Resources

$15.71

-0.11 (-0.70%)

20:03
12/05/19
12/05
20:03
12/05/19
20:03
Hot Stocks
Royal Gold updates on Andacollo Workers Union ratifying 36-month collective deal »

Royal Gold (RGLD)…

RGLD

Royal Gold

$117.91

0.64 (0.55%)

TECK

Teck Resources

$15.71

-0.11 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IR

Ingersoll-Rand

$128.95

1.405 (1.10%)

19:41
12/05/19
12/05
19:41
12/05/19
19:41
Upgrade
Ingersoll-Rand rating change at Wells Fargo »

Ingersoll-Rand upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$119.86

2.42 (2.06%)

19:06
12/05/19
12/05
19:06
12/05/19
19:06
Hot Stocks
Intercept Phase 3 study for OCA in fibrosis patients published in The Lancet »

Intercept announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

HUN

Huntsman

$22.34

0.37 (1.68%)

18:52
12/05/19
12/05
18:52
12/05/19
18:52
Hot Stocks
Huntsman acquires Icynene-Lapolla for all-cash payment of $350M »

Huntsman announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

UBER

Uber

$28.65

-0.405 (-1.39%)

18:48
12/05/19
12/05
18:48
12/05/19
18:48
Hot Stocks
Uber: Non-consensual kissing of sexual body part reported in 1 in 3M U.S. trips »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.65

-0.405 (-1.39%)

18:45
12/05/19
12/05
18:45
12/05/19
18:45
Hot Stocks
Uber says fatal physical assault reported in 1 in every 122M U.S. trips »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOMO

Domo

$19.47

-0.19 (-0.97%)

, EZPW

Ezcorp

$5.21

-0.01 (-0.19%)

18:44
12/05/19
12/05
18:44
12/05/19
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Domo…

DOMO

Domo

$19.47

-0.19 (-0.97%)

EZPW

Ezcorp

$5.21

-0.01 (-0.19%)

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

CLDR

Cloudera

$10.02

0.16 (1.62%)

MDLA

Medallia

$29.79

0.55 (1.88%)

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

AOBC

American Outdoor Brands

$9.42

0.38 (4.20%)

YEXT

Yext

$16.62

0.065 (0.39%)

PD

PagerDuty

$24.99

-0.66 (-2.57%)

SAIC

SAIC

$83.82

-0.57 (-0.68%)

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

KFY

Korn/Ferry

$40.26

0.39 (0.98%)

COO

Cooper Companies

$313.10

1 (0.32%)

GWRE

Guidewire

$119.32

0.68 (0.57%)

OKTA

Okta

$119.18

-2.64 (-2.17%)

UBER

Uber

$28.65

-0.405 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 16

    Dec

  • 17

    Dec

  • 17

    Dec

UBER

Uber

$28.65

-0.405 (-1.39%)

18:43
12/05/19
12/05
18:43
12/05/19
18:43
Hot Stocks
Uber says 107 total fatalities in 2017-2018 reported in relation to Uber app »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.65

-0.405 (-1.39%)

18:34
12/05/19
12/05
18:34
12/05/19
18:34
Periodicals
Breaking Periodicals news story on Uber »

Uber reports 3,000 sexual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$819.61

10.12 (1.25%)

18:33
12/05/19
12/05
18:33
12/05/19
18:33
Hot Stocks
Chipotle CEO: I took time to understand what makes us unique »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$26.02

0.36 (1.40%)

18:17
12/05/19
12/05
18:17
12/05/19
18:17
Hot Stocks
Rent-A-Center raises quarterly dividend to 29c from 25c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$76.66

0.01 (0.01%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Black Hills utilities receive approval to upsize Renewable Ready program »

Black Hills announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$21.92

0.3 (1.39%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Primoris awarded two pipeline contracts for over $45M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$35.94

-0.09 (-0.25%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
LeMaitre CFO sells 121K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLBK

Columbia Financial

$16.33

-0.24 (-1.45%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
Columbia Financial expands stock buyback to acquire additional 3M shares »

Columbia Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXS

Axis Capital

$58.42

0.31 (0.53%)

17:49
12/05/19
12/05
17:49
12/05/19
17:49
Hot Stocks
Axis Capital increases quarterly dividend 2.5% to 41c per share »

Axis Capital has declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PZZA

Papa John's

$59.67

-0.53 (-0.88%)

17:48
12/05/19
12/05
17:48
12/05/19
17:48
Periodicals
Former Papa John's CEO files suit against ad firm, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

THG

Hanover Insurance

$133.80

0.52 (0.39%)

17:47
12/05/19
12/05
17:47
12/05/19
17:47
Hot Stocks
Hanover Insurance raises dividend to 65c/shr, announces $2.50 special dividend »

The Hanover Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

17:46
12/05/19
12/05
17:46
12/05/19
17:46
Hot Stocks
Biohaven Pharmaceutical issued patent relating to troriluzole »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

17:45
12/05/19
12/05
17:45
12/05/19
17:45
Upgrade
Morgan Stanley upgrades Epizyme to Overweight ahead of lymphoma data »

Morgan Stanley analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.